- Technology and Data
- Front End Sales and Marketing
- Allergy
- HIV
- Women's Health
- Migraine
- Compounding
- Continuous Glucose Monitoring
- Mental Health Awareness
- Veterinary Pharmacy
- CBD
- Infectious Disease
- Eye Health
- Digestive Health
- Biosimilars
- Influenza
- Shingles
- COPD Management
- Pediatrics
- Generics
- Pain Management
- COVID-19
- Immunization
- Oncology
- Anticoagulants
- Autoimmune Diseases
- Dermatology
- Diabetes
- Respiratory
- Heart Health
- Cardiovascular Clinical Consult
CMS sued over Medicare refund
In response to a lawsuit filed by the Center for Medicare Advocacy, CMS has agreed to halt its efforts to recover the more than $50 million it mistakenly sent some 230,000 Medicare beneficiaries.
In response to a lawsuit filed by the Center for Medicare Advocacy, CMS has agreed to halt its efforts to recover the more than $50 million it mistakenly sent some 230,000 Medicare beneficiaries. The lawsuit alleges that CMS did not properly inform beneficiaries that they may have the right to ask for a waiver, excusing them from repaying the refund. Waiver of recovery where the beneficiary is not at fault in causing the overpayment and where certain other conditions exist is provided by statute for many government benefit programs in recognition of the hardship that recovery might cause for beneficiaries with fixed low incomes. A hearing on the preliminary injunction has been scheduled for Sept. 26.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
Examining Barriers to Care in Diabetic Retinopathy Screening
November 30th 2023Prior research has shown the association between various socioeconomic variables and lower adherence to diabetic retinopathy screening, but few have elaborated on the patient perspective to understand the reason behind this association.
